A new £2.6m project led by Swansea University aims to dramatically improve the diagnosis and treatment of ovarian cancer, one of the deadliest forms of cancer for women. Swansea University says the Cluster for Epigenomic and Antibody Drug Conjugate (ADC) Therapeutics (CEAT) has been awarded £1.2m from the European Regional Development Fund via the Welsh … Continue reading New project aims to offer treatment for ovarian cancer